May 3, 2023
Synergyne ART Analytics Inc. and Cybera’s Applied Data Science Lab Join Forces to Advance Fertility Treatment, Artificial Intelligence in Medical Tech
Synergyne ART Analytics Inc. and Cybera’s Applied Data Science Lab are proud to announce their collaboration to advance fertility treatment and artificial intelligence/machine learning(AI/ML) within the medical technology (MedTech) industry.
March 7, 2023
Synergyne ART Analytics Inc. enters into a Memorandum of Understanding with HoMu Health Ventures
Steve Rowley, VP for Synergyne, states “The team at HoMu brings additional scientific knowledge, clinic relationships and proven commercialization expertise in developing advanced reproductive technologies which improve IVF outcomes.
April 4, 2022
Canadian Reproductive Tool for IVF Patients Expands Globally to Become First Fully AI Medtech of its Kind
Matris ™ by Synergyne ART Analytics Inc., enters the next phase to become the world’s first and only artificially intelligent fertility technology of its kind — opening the door for improved pregnancy rates for IVF patients everywhere. World-leading US fertility clinic and foremost research hub, Boston IVF, will take the tool across the border to validate the improvement in the IVF success rates achieved in Canada.